Menu
Back to Journals » Drug Design, Development and Therapy » Volume 13
Review
Brigatinib for ALK-positive metastatic non-small-cell lung cancer: design, development and place in therapy
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 11,611 | Dovepress* | 7,803+ | 1,563 | 9,366 | |
| PubMed Central* | 3,808 | 836 | 4,644 | ||
| Totals | 11,611 | 2,399 | 14,010 | ||
| *Since 8 February 2019 | |||||
View citations on PubMed Central and Google Scholar